Cargando…
ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
PURPOSE: TNF-α is a transmembrane protein which requires cleavage by ADAM17 in order to act systemically. The activation of ADAM17 to generate soluble TNF‑α results in an increased inflammatory activity. We hypothesized that variants spanning the ADAM17 gene contribute towards the observed variation...
Autores principales: | Kim, Hyun Jeong, Trinh, Nga Thi, Choi, Yunjeong, Kim, Woorim, Min, Kyung Hyun, Kang, Sang Oh, Kim, Joo Hee, Kim, Hyoun-Ah, Jung, Ju-Yang, Choi, In Ah, Lee, Kyung Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083627/ https://www.ncbi.nlm.nih.gov/pubmed/32214841 http://dx.doi.org/10.2147/PGPM.S235035 |
Ejemplares similares
-
Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models
por: Kim, Woorim, et al.
Publicado: (2021) -
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016) -
Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea
por: Choi, In Ah, et al.
Publicado: (2016) -
Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis
por: Gu, Ki-Nam, et al.
Publicado: (2019) -
The Influence of Vertebral Fracture on the Functional Disability of Patients with Rheumatoid Arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2014)